In Brief: Trylon's Pap Plus Speculoscopy
This article was originally published in The Gray Sheet
Trylon's Pap Plus Speculoscopy: Visual cervical screening exam using the firm's Speculite disposable chemiluminescent illuminator receives FDA 510(k) clearance for the claim that it increases the sensitivity of screening, when compared with Pap smear alone, from 40% to 90%, according to the Torrance, California-based firm. Specificity, however, decreases from 95% to 80%. The firm also will provide participating Planned Parenthood clinics with the exam at no additional cost for low income, uninsured women who receive their cervical screening at the clinics...
You may also be interested in...
The C-suite leaders schemed to falsely record shipments of unwanted products to distributors as sales so the company could meet revenue projections, the government charged.
Gallium has been approved as a diagnostic agent by the US agency to help early detection of prostate cancer spread in patients who qualify for treatment with surgery or radiation therapy.
A joint report by the US Government Accountability Office and the National Academy of Sciences slams the FDA for dawdling on final software as a medical device rules.